| Citation: |
YAN Xinchun, HUO Li. Evaluation of Von Hippel-Lindau Syndrome Through Novel Small Molecular Tracer 68Ga-NY104 PET/CT Imaging[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 911-915. DOI: 10.12290/xhyxzz.2024-0216
|
VHL (von Hipple-Lindau) syndrome is a rare autosomal dominant genetic disease with complex and diverse clinical manifestations, which primarily presents as multiple tumors in the retina, central nervous system, kidneys, pancreas, and other areas. Patients often require comprehensive multi-organ assessment. Carbonic anhydrase Ⅸ (CAⅨ) is ubiquitously expressed in VHL-related lesions, and 68Ga-NY104, a novel small-molecule tracer, can perform whole-body imaging of CAⅨ-positive lesions. This case report introduces a 32-year-old female patient with VHL syndrome who underwent sequential 18F-FDG PET/CT and 68Ga-NY104 PET/CT for lesion assessment. Notably, 68Ga-NY104 PET/CT demonstrated uptake in a broader range of lesions (including renal, pancreatic, hepatic metastatic lesions and cerebellar lesions). This article discusses the process of evaluating the relevant lesions in this patient, with the aim of exploring a "one-stop" evaluation tool for patients with VHL syndrome.
| [1] |
Maddock I R, Moran A, Maher E R, et al. A genetic register for von Hippel-Lindau disease[J]. J Med Genet, 1996, 33(2): 120-127. DOI: 10.1136/jmg.33.2.120
|
| [2] |
Lonser R R, Glenn G M, Walther M, et al. Von Hippel-Lindau disease[J]. Lancet, 2003, 361(9374): 2059-2067. DOI: 10.1016/S0140-6736(03)13643-4
|
| [3] |
北京医学会罕见病分会. 中国von Hippel-Lindau病诊治专家共识[J]. 中华医学杂志, 2018, 98(28): 2220-2224. DOI: 10.3760/cma.j.issn.0376-2491.2018.28.002
Rare Diseases Branch of Beijing Medical Association. Consensus among Chinese experts in the diagnosis and treatment of von Hippel-Lindau disease[J]. Natl Med J China, 2018, 98(28): 2220-2224. DOI: 10.3760/cma.j.issn.0376-2491.2018.28.002
|
| [4] |
Filling-Katz M R, Choyke P L, Oldfield E, et al. Central nervous system involvement in von Hippel-Lindau disease[J]. Neurology, 1991, 41(1): 41-46. DOI: 10.1212/WNL.41.1.41
|
| [5] |
Walther M M, Choyke P L, Glenn G, et al. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery[J]. J Urol, 1999, 161(5): 1475-1479. DOI: 10.1016/S0022-5347(05)68930-6
|
| [6] |
Poston C D, Jaffe G S, Lubensky I A, et al. Characteriza-tion of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications[J]. J Urol, 1995, 153(1): 22-26. DOI: 10.1097/00005392-199501000-00009
|
| [7] |
Charlesworth M, Verbeke C S, Falk G A, et al. Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature[J]. J Gastrointest Surg, 2012, 16(7): 1422-1428. DOI: 10.1007/s11605-012-1847-0
|
| [8] |
Ganeshan D, Menias C O, Pickhardt P J, et al. Tumors in von Hippel-Lindau syndrome: from head to toe-comprehen-sive state-of-the-art review[J]. Radiographics, 2018, 38(3): 849-866. DOI: 10.1148/rg.2018170156
|
| [9] |
Leung R S, Biswas S V, Duncan M, et al. Imaging features of von Hippel-Lindau disease[J]. Radiographics, 2008, 28(1): 65-79. DOI: 10.1148/rg.281075052
|
| [10] |
Daniels A B, Tirosh A, Huntoon K, et al. Guidelines for surveillance of patients with von Hippel-Lindau disease: consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance[J]. Cancer, 2023, 129(19): 2927-2940. DOI: 10.1002/cncr.34896
|
| [11] |
de Campos N S P, Souza B S, Da Silva G C P, et al. Carbonic anhydrase Ⅸ: A renewed target for cancer immunotherapy[J]. Cancers (Basel), 2022, 14(6): 1392. DOI: 10.3390/cancers14061392
|
| [12] |
Chatzopoulos K, Aubry M C, Gupta S. Immunohistochemical expression of carbonic anhydrase 9, glucose transporter 1, and paired box 8 in von Hippel-Lindau disease-related lesions[J]. Hum Pathol, 2022, 123: 93-101. DOI: 10.1016/j.humpath.2022.02.009
|
| [13] |
Krall N, Pretto F, Mattarella M, et al. A 99mTc-labeled ligand of carbonic anhydrase Ⅸ selectively targets renal cell carcinoma in vivo[J]. J Nucl Med, 2016, 57(6): 943-949. DOI: 10.2967/jnumed.115.170514
|
| [14] |
Zhu W J, Li X Y, Zheng G Y, et al. Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase Ⅸ targeting PET tracer in clear cell renal cell carcinoma[J]. Eur J Nucl Med Mol Imaging, 2023, 50(10): 3116-3125. DOI: 10.1007/s00259-023-06248-7
|
| [1] | YAO Ru, HAO Zhixin, QU Yang, ZHANG Chao, LI Weijia, LANG Jie, PAN Bo, ZHOU Yidong, SUN Qiang, HUO Li. Novel 18F-FES PET/CT in Non-invasive Functional Diagnosis of Delayed Lung Metastasis Presented with Horner Syndrome in a Metastatic Breast Cancer Patient[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 702-707. DOI: 10.12290/xhyxzz.2023-0530 |
| [2] | ZHU Shikun, ZHANG Shu, LUO Yaping. SPECT/CT in Localization of Sentinel Lymph Node of Skin Tumors[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 795-801. DOI: 10.12290/xhyxzz.2023-0170 |
| [3] | GONG Tan, SHANG Fei, TANG Xiaoying, HUO Li, LIU Shuai. Relationship Between Pharmacokinetic Parameters and Imaging Duration in Dynamic 11C-Acetate Cardiac PET/CT[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 758-765. DOI: 10.12290/xhyxzz.2023-0121 |
| [4] | HAN Pingping, FU Liping, ZHANG Ling, FENG Hongxiang, SHI Yanfen, ZHENG Yumin. Analysis of the Features of 18F-FDG PET/CT and Enhanced CT in Patients with Primary Pulmonary Mucinous Adenocarcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 270-276. DOI: 10.12290/xhyxzz.2021-0705 |
| [5] | JIA Chenhao, WU Meiqi, GUO Ruijie, NI Jun, CUI Ruixue. Comparative Study of 18F-FDG PET/CT Metabolic Alteration Patterns in Cerebral Amyloid Angiopathy and Alzheimer's Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 263-269. DOI: 10.12290/xhyxzz.2021-0693 |
| [6] | LIU Yanting, ZHANG Lu, CHEN Miao, ZHANG Yan, WEI Chong, PAN Boju, ZHAO Jiawei. A Case of Small B-cell Lymphocytic Lymphoma Diagnosed One Year after Evans Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 423-426. DOI: 10.12290/xhyxzz.20200063 |
| [7] | XIAO Nan, LI Zhanfeng, YAO Jianxin, PAN Zhiyao, YAO Zhifeng. Long Non-coding RNA and Cancer Stem Cells[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 373-379. DOI: 10.12290/xhyxzz.20190231 |
| [8] | Xiao-na JIN, Nai-xin LIANG, Meng-zhao WANG, Bing JIA, Xi-min SHI, Shan-qing LI, Fang LI, Fan WANG, Zhao-hui ZHU. Integrin Receptor Imaging 99mTc-3PRGD2 SPECT/CT in Diagnosis and Lymph Node Staging of Non-Small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(5): 327-333. DOI: 10.3969/j.issn.1674-9081.2016.05.002 |
| [10] | Qing-jun WU, Zhang-han DAI, Wen ZHANG, Yong-zhe LI, Xin-ping TIAN, Xuan ZHANG, Yan ZHAO, Xiao-feng ZENG, Feng-chun ZHANG, Fu-lin TANG. Characteristics of Antisynthetase Syndrome with Anti-threonyl tRNA Synthetase Antibody[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(1): 26-30. DOI: 10.3969/j.issn.1674-9081.2013.01.006 |
| 1. |
程春玲，李鸿欣，陆敏，贾利平. 卵巢硬化性间质瘤1例并文献复习. 中国计划生育和妇产科. 2025(02): 35-37+40 .
| |
| 2. |
吴志羡，郑顺勇，黄庆文. 卵巢硬化性间质瘤的磁共振成像特征及其病理相特征分析. 中华灾害救援医学. 2024(11): 1280-1284 .
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: